Population Pharmacokinetics and Dosage Optimization of Linezolid in Critically Ill Pediatric Patients

Abstract
Linezolid is an oxazolidinone antibiotic exhibiting efficacy against multidrug-resistant (MDR) Gram-positive-related infections. However, its population pharmacokinetic (PopPK) profile in critically ill Chinese children has not been characterized.
Funding Information
  • Clinical Pharmacy Research Project of Beijing Pharmaceutical Association (2020)
  • Beijing Municipal Administration of Hospitals | Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201813)

This publication has 23 references indexed in Scilit: